Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes

Autor: Overgaard, Rune V., Hertz, Christin L., Ingwersen, Steen H., Navarria, Andrea, Drucker, Daniel J.
Zdroj: In Cell Reports Medicine 21 September 2021 2(9)
Databáze: ScienceDirect